tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ASND Stock Latest News

Positive Outlook for Ascendis Pharma: Buy Rating Despite PDUFA Delay
RatingsPositive Outlook for Ascendis Pharma: Buy Rating Despite PDUFA Delay
8d ago
ASND
Ascendis Pharma Faces FDA Delay for TransCon CNP Approval
PremiumCompany Announcements
Ascendis Pharma Faces FDA Delay for TransCon CNP Approval
8d ago
6K
ASND
Positive Outlook on Ascendis Pharma Despite PDUFA Date Extension for TransCon CNP
PremiumRatings
Positive Outlook on Ascendis Pharma Despite PDUFA Date Extension for TransCon CNP
9d ago
ASND
Ascendis Pharma annouces FDA extension for TransCon CN
PremiumThe Fly
Ascendis Pharma annouces FDA extension for TransCon CN
9d ago
ASND
FDA Calendar: These Are the Upcoming FDA Drug Approvals 
PremiumMarket News
FDA Calendar: These Are the Upcoming FDA Drug Approvals 
14d ago
ASND
KURA
Buy Rating for Ascendis Pharma Driven by Promising TransCon CNP Developments in Achondroplasia Treatment
PremiumRatingsBuy Rating for Ascendis Pharma Driven by Promising TransCon CNP Developments in Achondroplasia Treatment
16d ago
ASND
Ascendis Pharma initiated with an Outperform at Wolfe Research
Premium
The Fly
Ascendis Pharma initiated with an Outperform at Wolfe Research
17d ago
ASND
Ascendis Pharma publishes results from ApproaCH Trial in JAMA Pediatrics
Premium
The Fly
Ascendis Pharma publishes results from ApproaCH Trial in JAMA Pediatrics
17d ago
ASND
Ascendis Pharma A/S: Strong Growth and Strategic Challenges
PremiumCompany Announcements
Ascendis Pharma A/S: Strong Growth and Strategic Challenges
21d ago
ASND
Ascendis Pharma: Promising Growth and Strong Market Penetration Justify Buy Rating
PremiumRatings
Ascendis Pharma: Promising Growth and Strong Market Penetration Justify Buy Rating
21d ago
ASND
Strong Demand and Strategic Developments Drive Buy Rating for Ascendis Pharma
PremiumRatings
Strong Demand and Strategic Developments Drive Buy Rating for Ascendis Pharma
22d ago
ASND
Ascendis Pharma Reports Strong Q3 2025 Performance
PremiumCompany Announcements
Ascendis Pharma Reports Strong Q3 2025 Performance
22d ago
ASND
Closing Bell Movers: Cisco jumps 7% to record highs after beat-and-raise
PremiumThe FlyClosing Bell Movers: Cisco jumps 7% to record highs after beat-and-raise
22d ago
SG
DLO
Ascendis Pharma Grants Warrants to Employees in Strategic Move
Premium
Company Announcements
Ascendis Pharma Grants Warrants to Employees in Strategic Move
22d ago
6K
ASND
Ascendis Pharma Reports Q3 2025 Financial Results with Revenue Growth
Premium
Company Announcements
Ascendis Pharma Reports Q3 2025 Financial Results with Revenue Growth
22d ago
6K
ASND
Ascendis Pharma Achieves Strong Q3 2025 Financial Results Amid Product Expansion
PremiumCompany Announcements
Ascendis Pharma Achieves Strong Q3 2025 Financial Results Amid Product Expansion
22d ago
6K
ASND
Ascendis Pharma reports Q3 EPS (EUR 1.00) vs. (EUR 0.72) last year
PremiumThe Fly
Ascendis Pharma reports Q3 EPS (EUR 1.00) vs. (EUR 0.72) last year
22d ago
ASND
ASND Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ASND Earnings this Week: How Will it Perform?
25d ago
ASND
Ascendis Pharma announces new pooled analysis on TransCon PTH
PremiumThe Fly
Ascendis Pharma announces new pooled analysis on TransCon PTH
27d ago
ASND
Ascendis Pharma Launches Expanded SKYTROFA Dosing in U.S.
PremiumCompany AnnouncementsAscendis Pharma Launches Expanded SKYTROFA Dosing in U.S.
1M ago
6K
ASND
RBC Capital remains buyer of Ascendis, says patient death unlikely drug related
Premium
The Fly
RBC Capital remains buyer of Ascendis, says patient death unlikely drug related
2M ago
ASND
Ascendis Pharma weakness follows death reported in FAERS, says BofA
Premium
The Fly
Ascendis Pharma weakness follows death reported in FAERS, says BofA
2M ago
ASND

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >